HealthGenmab’s Cancer Combination Meets Both Primary Endpoints in Phase 3 TrialBy Naomi CalderOct 29, 2026, 12:09 AM UTC
HealthKelun-Biotech Reports Longer Progression-Free Survival in Phase 3 Lung TrialBy Naomi CalderOct 25, 2026, 10:50 AM UTC